ArticleIJID regions2025
Prevalence and characteristics of long COVID among COVID-19 survivors in Saudi Arabia: A cross-sectional study.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Determinants and Consequences of Long Impact of COVID-19: A National Cross-Sectional Study in Saudi Arabia.Journal of clinical medicine · 2026Article
- Symptoms, mechanisms, and management of long COVID: understanding its prevalence, characteristics, and healthcare challenges in Saudi Arabia.Frontiers in cellular and infection microbiology · 2026Review
- Pulmonary sequelae of SARS-CoV-2 infection: a narrative review of long-term functional, radiological, and clinical outcomes in COVID-19 survivors, with a regional focus on Saudi Arabia.Frontiers in physiology · 2026Review
- Long COVID Symptoms and Five Dimensions of HRQoL: A Retrospective Regional Study of Patients Recovered from COVID-19 Infection in Saudi Arabia.International journal of general medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study explores the prevalence, risk factors, and impact of long COVID among COVID-19 survivors in Saudi Arabia. Methods: A cross-sectional study involving 486 COVID-19 survivors was conducted. Participants were confirmed via polymerase chain reaction testing and enrolled from November 2020 to December 2020. Results: The study found a high prevalence of long COVID symptoms, with 61% of participants reporting persistent symptoms. The prevalence was similar across demographic factors: 43% were aged 18-30 years, 71% were female, and 30% had comorbidities. The most common symptoms included fatigue (56%), breathlessness (47%), loss of smell (44%), and muscle aches (40%), alongside digestive issues, chest pain, headaches, tachycardia, joint pain, and skin problems. Conclusions: This study underscores the significance of understanding long COVID's impact on individuals' health and quality of life. It highlights the necessity for further research to guide health care strategies and support COVID-19 survivors in Saudi Arabia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.